Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
McKinsey
Covington
Dow
US Department of Justice
Chinese Patent Office
Healthtrust
Boehringer Ingelheim
Moodys
Cipla

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,475,491

« Back to Dashboard

Summary for Patent: 6,475,491
Title: Treatment of HIV and other viral infections using combinatorial therapy
Abstract:Novel antiviral combinations for the treatment or prevention of viral infections, in particular, HIV, are disclosed. This new antiviral therapy employs either DP-178 or DP-107, viral fusion inhibitors, in combination with at least one other antiviral therapeutic agent. The combinations of the invention are better than single therapies alone, and in certain cases are synergistic. The use of DP-178 or DP-107 is an ideal therapy to combine with another antiviral, given both the novel mechanism which this therapeutic blocks HIV transmission and the non-toxicity of the therapeutic.
Inventor(s): Johnson; M. Ross (Chapel Hill, NC), Lambert; Dennis Michael (Cary, NC)
Assignee: Trimeris, Inc. (Durham, NC)
Application Number:08/973,952
Patent Claim Types:
see list of patent claims
Use; Dosage form; Composition;

Drugs Protected by US Patent 6,475,491

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,475,491

PCT Information
PCT FiledJune 06, 1996PCT Application Number:PCT/US96/09499
PCT Publication Date:December 19, 1996PCT Publication Number: WO96/40191

International Patents Family Members for US Patent 6,475,491

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 6261996 ➤ Try a Free Trial
Australia 723537 ➤ Try a Free Trial
Brazil 9609152 ➤ Try a Free Trial
Canada 2224008 ➤ Try a Free Trial
China 1192688 ➤ Try a Free Trial
European Patent Office 0831873 ➤ Try a Free Trial
Japan H11507632 ➤ Try a Free Trial
Mexico 9709682 ➤ Try a Free Trial
New Zealand 311319 ➤ Try a Free Trial
World Intellectual Property Organization (WIPO) 9640191 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cantor Fitzgerald
Argus Health
Accenture
Harvard Business School
Boehringer Ingelheim
Merck
Daiichi Sankyo
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot